Preliminary experience of Tubridge Plus flow diverter in the treatment of intracranial aneurysms - Summary - MDSpire

Preliminary experience of Tubridge Plus flow diverter in the treatment of intracranial aneurysms

  • By

  • Tao Zhang

  • Xing Guo

  • Yufeng Liu

  • Guoqiang Luo

  • Wei Fang

  • Hu Chen

  • Haiyang Jiang

  • Zijian Yang

  • Yue Si

  • Dayun Feng

  • Zhenwei Zhao

  • Jianping Deng

  • July 9, 2026

  • 0 min

Share

Objective:

To report preliminary experience using the Tubridge Plus flow diverter (TPFD) for intracranial aneurysms (IAs), evaluating its technical feasibility, efficacy, safety, and outcomes.

Approach:
  • Study Design: A single-center prospective study involving 10 consecutive patients with 10 IAs treated with TPFD.
  • Data Collection: Technical success, intraoperative adverse events, and angiographic outcomes were collected and analyzed.
Key Findings:
  • Technical success rate for TPFD delivery and deployment was 100%.
  • Intraoperative adverse events occurred in 2 patients (20%), both managed with adjunctive stenting.
  • No perioperative complications were recorded.
  • Transient postoperative headache occurred in 1 patient (10%).
  • Complete occlusion rates improved over time: 60% at 6 months, 80% at 1 year, and 90% at last follow-up.
  • No in-stent stenosis or ipsilateral stroke was recorded during follow-up.
Interpretation:

Limitations:
  • Small sample size.
  • Single-center design.
  • Short follow-up duration.
Conclusion:

Further large-scale, multicenter studies with long-term follow-up are warranted to validate the safety and efficacy of TPFD.

Original Source(s)

Related Content